- Home
- NQP vs PSNL Comparison
NQP vs PSNL Comparison
Compare NQP & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NQP
- PSNL
- Stock Information
- Founded
- NQP 1990
- PSNL 2011
- Country
- NQP United States
- PSNL United States
- Employees
- NQP N/A
- PSNL N/A
- Industry
- NQP Trusts Except Educational Religious and Charitable
- PSNL Medical Specialities
- Sector
- NQP Finance
- PSNL Health Care
- Exchange
- NQP Nasdaq
- PSNL Nasdaq
- Market Cap
- NQP 408.3M
- PSNL 460.7M
- IPO Year
- NQP N/A
- PSNL 2019
- Fundamental
- Price
- NQP $11.02
- PSNL $3.19
- Analyst Decision
- NQP
- PSNL Strong Buy
- Analyst Count
- NQP 0
- PSNL 5
- Target Price
- NQP N/A
- PSNL $7.80
- AVG Volume (30 Days)
- NQP 58.4K
- PSNL 733.3K
- Earning Date
- NQP 01-01-0001
- PSNL 05-07-2025
- Dividend Yield
- NQP 3.21%
- PSNL N/A
- EPS Growth
- NQP N/A
- PSNL N/A
- EPS
- NQP N/A
- PSNL N/A
- Revenue
- NQP N/A
- PSNL $84,614,000.00
- Revenue This Year
- NQP N/A
- PSNL N/A
- Revenue Next Year
- NQP N/A
- PSNL $27.78
- P/E Ratio
- NQP N/A
- PSNL N/A
- Revenue Growth
- NQP N/A
- PSNL 15.15
- 52 Week Low
- NQP $9.65
- PSNL $1.14
- 52 Week High
- NQP $11.89
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- NQP 40.92
- PSNL 42.50
- Support Level
- NQP $11.00
- PSNL $2.86
- Resistance Level
- NQP $11.23
- PSNL $3.40
- Average True Range (ATR)
- NQP 0.19
- PSNL 0.33
- MACD
- NQP -0.01
- PSNL 0.04
- Stochastic Oscillator
- NQP 43.02
- PSNL 40.27
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state, and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.